about
Statin-Associated Muscle Adverse Events: Update for cliniciansSAK-HV Triggered a Short-period Lipid-lowering Biotherapy Based on the Energy Model of Liver Proliferation via a Novel Pathway.PPARα: A Master Regulator of Bilirubin HomeostasisDyslipidaemia and the military patient.Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention.Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia.Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs.
P2860
Q28074144-5F13C385-FADB-47B8-B94E-8A187715B126Q33703148-648BACA1-5421-4853-B173-52A51196FD53Q34053116-6B1400BB-4C90-4008-AADC-4B9B1EA779A2Q38561477-ABE51E02-F62E-4389-8060-A6A1492CA037Q39004398-73344D54-4F89-49F2-B37E-6DCB65755EAFQ47303571-4E8F0515-7734-4C7F-9A7C-5943E4555CA3Q47801493-DE10DFC7-C326-4370-AEEC-C3AACBBAEF24Q48526234-FF5C0DC9-0888-4B32-887B-6F0CD026E4C8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lipid-lowering agents.
@en
type
label
Lipid-lowering agents.
@en
prefLabel
Lipid-lowering agents.
@en
P2860
P356
P1476
Lipid-lowering agents.
@en
P2093
Mfon Ewang-Emukowhate
P2860
P304
P356
10.1177/1074248413492906
P577
2013-06-27T00:00:00Z